BSE Live
Mar 24, 16:01Prev. Close
36.63
Open Price
37.36
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 24, 15:15Prev. Close
36.62
Open Price
0.00
Bid Price (Qty.)
41.30 (35)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Take Solutions (in Rs. Cr.) | Mar 05 | Mar 04 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 4.13 | 0.63 | |
| Diluted EPS (Rs.) | 4.13 | 0.63 | |
| Cash EPS (Rs.) | 6.18 | 2.19 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 18.04 | 13.92 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 18.04 | 13.92 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 33.68 | 18.46 | |
| PBDIT/Share (Rs.) | 6.78 | 1.09 | |
| PBIT/Share (Rs.) | 6.56 | 0.90 | |
| PBT/Share (Rs.) | 6.51 | 0.86 | |
| Net Profit/Share (Rs.) | 4.13 | 0.63 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 20.13 | 5.91 | |
| PBIT Margin (%) | 19.49 | 4.88 | |
| PBT Margin (%) | 19.32 | 4.63 | |
| Net Profit Margin (%) | 12.24 | 3.42 | |
| Return on Networth / Equity (%) | 22.86 | 4.54 | |
| Return on Capital Employed (%) | 22.20 | 4.50 | |
| Return on Assets (%) | 17.50 | 3.76 | |
| Total Debt/Equity (X) | 0.06 | 0.01 | |
| Asset Turnover Ratio (%) | 142.94 | 109.86 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 3.91 | 5.02 | |
| Quick Ratio (X) | 3.79 | 4.84 | |
| Inventory Turnover Ratio (X) | 54.12 | 37.58 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 100.00 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 100.00 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | |
| Retention Ratios (%) | 100.00 | 100.00 | |
| Price/BV (X) | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 |
01.01.2026
14.06.2024
Take Solutions Consolidated March 2024 Net Sales at Rs 13.21 crore, down 64.82% Y-o-Y
22.02.2024
Take Solutions Consolidated December 2023 Net Sales at Rs 16.85 crore, down 68.56% Y-o-Y
09.11.2023
Take Solutions Consolidated September 2023 Net Sales at Rs 18.09 crore, down 59.69% Y-o-Y
14.06.2024
Take Solutions Consolidated March 2024 Net Sales at Rs 13.21 crore, down 64.82% Y-o-Y
22.02.2024
Take Solutions Consolidated December 2023 Net Sales at Rs 16.85 crore, down 68.56% Y-o-Y
09.11.2023
Take Solutions Consolidated September 2023 Net Sales at Rs 18.09 crore, down 59.69% Y-o-Y
16.08.2023
Take Solutions Standalone June 2023 Net Sales at Rs 5.42 crore, down 59.51% Y-o-Y
24.03.2026
24.03.2026
23.03.2026
Alkem Laboratories gets DCGI nod for Semaglutide Injection; share price fall marginally
23.03.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth